InvestorsHub Logo
Followers 205
Posts 9789
Boards Moderated 6
Alias Born 10/02/2010

Re: steadyhand post# 18632

Thursday, 10/18/2018 1:13:29 AM

Thursday, October 18, 2018 1:13:29 AM

Post# of 21373
Hey there steadyhand, absolutely.

Oncolix will be at 50 cents by next year. Wait and see....



300,000 shares of ONCX at a cost basis average of .02 is $6,000.

With a historical ONCX bottom of roughly .01, the potential loss would be around $3,000.

300,000 shares that bounce to the previous high of $.20 would be $60,000.

With the conservative target price of .50, if FDA results are positive, would result in 300,000 ONCX shares being worth $150,000.

How many times have we discussed risk/reward ratios on the ONCX board?

I actually enjoy the ONCX debate and jibber/jabber.

Seriously though, we are looking at a $3,000 VAR against a potential $140,000 ROI.

Investors will probably not see odds like this again anytime soon on any OTC stock and it is shocking that people continue to squander this opportunity.

C'est la vie.

IMO and FWIW.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.